Comments
Heart attack risk seen with Boehringer clot drug
10.01.2012. | (Reuters) - Boehringer Ingelheim's Pradaxa blood clot preventer has been associated with a slightly higher risk of heart attack or acute coronary syndrome, according to results of a meta-analysis of several studies reported in a major medical journal....
